Table 2.
Clinical information and treatment of 16 patients with recurrent PEMa
| Recurrent cases, No | Number of lesions | Size of lesions, cm | ASIb | Preoperative GnRH-ac | Postoperative Hormone therapy | Disease-free interval, mo | Size of recurrent lesion, cm | Treatment for recurrence |
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 2.0; 1.5 | MPAd | 72 | 2 | Bilateral oophorectomy and total hysterectomy | ||
| 2 | 1 | 2.5 | Y | GnRH-a | 96 | 3 | Intravaginal radiation | |
| 3 | 2 | 5.0; 1.0 | Y | GnRH-a | 3 | 3 | Surgical excision, GnRH-a | |
| 4 | 1 | 2.5 | 30 | 3 | Surgical excision, GnRH-a | |||
| 5 | 1 | 2 | Y | Y | Gestrinone | 3 | 2.5 | Surgical excision, GnRH-a |
| 6 | 2 | 3.5; 2.5 | Y | Y | GnRH-a | 60 | 1.5 | GnRH-a, COCse |
| 7 | 2 | 4.0; 1.0 | Y | Y | GnRH-a | 15 | 2 | LNG-IUSf |
| 8 | 2 | 2.0; 1.0 | Y | COCs | 24 | 1.5 | GnRH-a, COCs | |
| 9 | 2 | 3.0; 1.5 | Y | Y | 36 | 2.0, rectum involved | Surgical excision, LNG-IUS | |
| 10 | 1 | 2.5 | 99 | 1.3 | COCs | |||
| 11 | 2 | 2.0; 1.0 | Y | Y | LNG-IUS | 6 | 3 | GnRH-a, COCs, LNG-IUS |
| 12 | 2 | 2.5; 1.0 | GnRH-a | 4 | 1 | TCMg | ||
| 13 | 1 | 3 | Y | Y | GnRH-a | 12 | 1.5 | COCs |
| 14 | 2 | 3.0; 2.0 | Y | Y | 12 | 2 | COCs | |
| 15 | 1 | 3 | Y | Y | GnRH-a | 6 | 1 | LNG-IUS |
| 16 | 2 | 2.0; 0.5 | Y | GnRH-a | 26 | 3 | Surgical excision, GnRH-a |
aPEM perineal endometriosis; bASI anal sphincter involvement; cGnRH-a gonadotrophin-releasing hormone agonist; dMPA medroxyprogesterone acetate; eCOCs combined oral contraceptives; fLNG-IUS levonorgestrel-releasing intra-uterine system; gTCM: traditional chinese medicine